Synthesis, characterization, antioxidant, and anticancer studies of 6-[3-(4-chlorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl][1,2,4]triazolo[3,4-b][1,3,4]thiadiazole in HepG2 cell lines
✍ Scribed by Dhanya Sunil; Arun M. Isloor; Prakash Shetty; K. Satyamoorthy; A. S. Bharath Prasad
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 386 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1054-2523
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract magnified image A series of 3‐alkyl/aryl substituted‐6‐((1__H__‐benzo[__d__][1,2,3]triazol‐1‐yl)methyl)‐[1,2,4]triazolo[3,4‐__b__][1, 3,4]thiadizoles **4a**, **4b**, **4c**, **4d**, **4e**, **4f**, **4g**, **4h**, **4i**, **4j**, **4k**, **4l**, **4m** are prepared by the condensation o
In the title compound, C 17 H 12 F 2 N 4 S, the six-membered thiadiazine ring is distorted from planarity and may be regarded as having a half-chair conformation, with an r.m.s deviation of 0.221 A ˚. The delocalized triazole ring has normal bond lengths.